ArticleInflammatory intestinal diseases

Long-Term Outcomes and Prognostic Factors for Vedolizumab-Treated Japanese Patients with Ulcerative Colitis.

Shinya Fukushima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.